Rituximab treatment in pediatric-onset multiple sclerosis

MLA

Breu, Markus, et al. Rituximab Treatment in Pediatric-Onset Multiple Sclerosis. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1428134657&authtype=sso&custid=ns315887.

APA

Breu, M., Sandesjö, F., Milos, R.-I., Svoboda, J., Salzer, J., Schneider, L., Reichelt, J. B., Bertolini, A., Blaschek, A., Fink, K., Höftberger, R., Lycke, J., Rostásy, K., Seidl, R., Siegert, S., Wickström, R., & Kornek, B. (2024). Rituximab treatment in pediatric-onset multiple sclerosis.

Chicago

Breu, Markus, Fredrik Sandesjö, Ruxandra-Iulia Milos, Jan Svoboda, Jonatan Salzer, Lisa Schneider, Julian Benedikt Reichelt, et al. 2024. “Rituximab Treatment in Pediatric-Onset Multiple Sclerosis.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1428134657&authtype=sso&custid=ns315887.